The University of Toronto-spin-out which works on molecular diagnostics has landed $10m in a series A round partially funded by Qiagen, a testing technology company.

The molecular diagnostics startup has landed $10m in a series A round partially funded by Qiagen, a molecular diagnostics and testing technology company.

NanoSemiconductor corporation Kopin is among the investors backing ski-based microdisplay company Recon, which has raised $10m in series A financing.

Monsanto and GlaxoSmithKline are joining founder investor Atlas Venture in financing RaNA Therapeutics, which specialises in genetic research.

The deal backing the internet telephone company was reportedly the first by the Cisco-backed Lebanon Growth Capital Fund, which invested alongside Intel Capital.

The A round included venture capital firms Social+Capital Partnership, IA Ventures and other angel investor Joel Spolsky alongside Professor Kearns.

The medical diagnostics company, which specialises in cancer treatments, has closed its series A round with investors including Aeris Capital, the venture firm set up by a SAP co-founder.